European heart journal. Imaging methods and practice · 2026
Altered caval flow and wall shear stress in single ventricle circulation: insights from ferumoxytol-enhanced 4D flow MRI.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suresh Kumar Vasupradha, Kollar Sarah, Vegulla Ravi V, Almarkhan Areen, Waberski Andrew, Loke Yue-Hin
Аннотация
AIMS: Patients with single ventricle (SV) congenital heart disease typically undergo surgical palliation that reroutes the superior/inferior vena cava (SVC/IVC) directly to the pulmonary arteries, which alters vascular flow dynamics. Four-dimensional flow (4DF) cardiovascular magnetic resonance (CMR), particularly with ferumoxytol contrast, enables comprehensive assessment of flow distribution and wall shear stress (WSS) in small paediatric vessels. This study aimed to evaluate the differences in caval flow and WSS between SV and BiV patients.
METHODS AND RESULTS: We retrospectively analysed patients who underwent clinically indicated ferumoxytol-enhanced (FE) 4DF CMR between 2019 and 2024. Patients with anomalous systemic or pulmonary venous return were excluded. 4DF data were evaluated on the cloud-based Tempus platform. Flow in the SVC, IVC, aorta, and descending aorta was quantified and indexed to the body surface area. The average WSS over time was measured. Among 387 patients (n = 126 for SV; n = 261 for BiV), SV patients had lower indexed SVC flow (1.11 ± 0.51 vs. 1.50 ± 0.69 L/min/m2, P < 0.0001) and lower WSS (16.0 ± 6.4 vs. 22.7 ± 9.1 cPa, P < 0.0001) compared with BiV patients. The SVC/caval flow ratio declined with age and body surface area, remaining independently lower in the SV group after multivariable adjustment (P = 0.0005).
CONCLUSION: SV physiology is associated with lower SVC flow and WSS independent of age or body size, suggesting altered systemic venous return intrinsic to cavopulmonary circulation. 4DF CMR is a valuable tool for assessing and monitoring systemic venous physiology in congenital heart disease.
METHODS AND RESULTS: We retrospectively analysed patients who underwent clinically indicated ferumoxytol-enhanced (FE) 4DF CMR between 2019 and 2024. Patients with anomalous systemic or pulmonary venous return were excluded. 4DF data were evaluated on the cloud-based Tempus platform. Flow in the SVC, IVC, aorta, and descending aorta was quantified and indexed to the body surface area. The average WSS over time was measured. Among 387 patients (n = 126 for SV; n = 261 for BiV), SV patients had lower indexed SVC flow (1.11 ± 0.51 vs. 1.50 ± 0.69 L/min/m2, P < 0.0001) and lower WSS (16.0 ± 6.4 vs. 22.7 ± 9.1 cPa, P < 0.0001) compared with BiV patients. The SVC/caval flow ratio declined with age and body surface area, remaining independently lower in the SV group after multivariable adjustment (P = 0.0005).
CONCLUSION: SV physiology is associated with lower SVC flow and WSS independent of age or body size, suggesting altered systemic venous return intrinsic to cavopulmonary circulation. 4DF CMR is a valuable tool for assessing and monitoring systemic venous physiology in congenital heart disease.